全文获取类型
收费全文 | 1705篇 |
免费 | 136篇 |
国内免费 | 224篇 |
专业分类
电工技术 | 28篇 |
综合类 | 97篇 |
化学工业 | 457篇 |
金属工艺 | 221篇 |
机械仪表 | 38篇 |
建筑科学 | 161篇 |
矿业工程 | 14篇 |
能源动力 | 19篇 |
轻工业 | 318篇 |
水利工程 | 18篇 |
石油天然气 | 28篇 |
武器工业 | 6篇 |
无线电 | 29篇 |
一般工业技术 | 164篇 |
冶金工业 | 174篇 |
原子能技术 | 257篇 |
自动化技术 | 36篇 |
出版年
2024年 | 5篇 |
2023年 | 54篇 |
2022年 | 199篇 |
2021年 | 210篇 |
2020年 | 99篇 |
2019年 | 79篇 |
2018年 | 67篇 |
2017年 | 87篇 |
2016年 | 85篇 |
2015年 | 72篇 |
2014年 | 114篇 |
2013年 | 147篇 |
2012年 | 94篇 |
2011年 | 139篇 |
2010年 | 88篇 |
2009年 | 70篇 |
2008年 | 55篇 |
2007年 | 72篇 |
2006年 | 58篇 |
2005年 | 57篇 |
2004年 | 57篇 |
2003年 | 25篇 |
2002年 | 37篇 |
2001年 | 20篇 |
2000年 | 10篇 |
1999年 | 7篇 |
1998年 | 8篇 |
1997年 | 7篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1993年 | 6篇 |
1990年 | 1篇 |
1989年 | 4篇 |
1988年 | 1篇 |
1987年 | 1篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1964年 | 1篇 |
1963年 | 2篇 |
1959年 | 5篇 |
1957年 | 1篇 |
1956年 | 1篇 |
1951年 | 1篇 |
排序方式: 共有2065条查询结果,搜索用时 14 毫秒
61.
John Dixon Katie Lane Iain MacPhee Barbara Philips 《International journal of molecular sciences》2014,15(2):2538-2553
Acute kidney injury (AKI) is a common complication of critical illness, and evidence is emerging that suggests AKI disrupts the function of other organs. It is a recognized phenomenon that patients with chronic kidney disease (CKD) have reduced hepatic metabolism of drugs, via the cytochrome P450 (CYP) enzyme group, and drug dosing guidelines in AKI are often extrapolated from data obtained from patients with CKD. This approach, however, is flawed because several confounding factors exist in AKI. The data from animal studies investigating the effects of AKI on CYP activity are conflicting, although the results of the majority do suggest that AKI impairs hepatic CYP activity. More recently, human study data have also demonstrated decreased CYP activity associated with AKI, in particular the CYP3A subtypes. Furthermore, preliminary data suggest that patients expressing the functional allele variant CYP3A5*1 may be protected from the deleterious effects of AKI when compared with patients homozygous for the variant CYP3A5*3, which codes for a non-functional protein. In conclusion, there is a need to individualize drug prescribing, particularly for the more sick and vulnerable patients, but this needs to be explored in greater depth. 相似文献
62.
Wei-Lun Tsai Wei-Chi Sun Jin-Shiung Cheng 《International journal of molecular sciences》2015,16(12):28126-28145
Chronic hepatitis B virus (HBV) infection is a major global health problem with an estimated 400 million HBV carriers worldwide. In the natural history of chronic hepatitis B (CHB), spontaneous acute exacerbation (AE) is not uncommon, with a cumulative incidence of 10%–30% every year. While exacerbations can be mild, some patients may develop hepatic decompensation and even die. The underlying pathogenesis is possibly related to the activation of cytotoxic T lymphocyte-mediated immune response against HBV. An upsurge of serum HBV DNA usually precedes the rise of alanine aminotransferase (ALT) and bilirubin. Whether antiviral treatment can benefit CHB with severe AE remains controversial, but early nucleos(t)ide analogues treatment seemed to be associated with an improved outcome. There has been no randomized study that compared the effects of different nucleos(t)ide analogues (NA) in the setting of CHB with severe AE. However, potent NAs with good resistance profiles are recommended. In this review, we summarized current knowledge regarding the natural history, pathogenetic mechanisms, and therapeutic options of CHB with severe AE. 相似文献
63.
Akinobu Takaki Tetsuya Yasunaka Takahito Yagi 《International journal of molecular sciences》2015,16(8):17494-17513
Hepatitis B often progresses to decompensated liver cirrhosis requiring orthotopic liver transplantation (OLT). Although newer nucleos(t)ide analogues result in >90% viral and hepatitis activity control, severely decompensated patients still need OLT because of drug-resistant virus, acute exacerbation, or hepatocellular carcinoma. Acute hepatitis B is also an indication for OLT, because it can progress to fatal acute liver failure. After OLT, the hepatitis B recurrence rate is >80% without prevention, while >90% of transplant recipients are clinically controlled with combined hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogue treatment. However, long-term HBIG administration is associated with several unresolved issues, including limited availability and extremely high cost; therefore, several treatment protocols with low-dose HBIG, combined with nucleos(t)ide analogues, have been investigated. Another approach is to induce self-producing anti-hepatitis B virus (HBV) antibodies using an HBV envelope (HBs) antigen vaccine. Patients who are not HBV carriers, such as those with acutely infected liver failure, are good candidates for vaccination. For chronic HBV carrier liver cirrhosis patients, a successful vaccine response can only be achieved in selected patients, such as those treated with experimentally reduced immunosuppression protocols. The present protocol for post-OLT HBV control and the future prospects of newer treatment strategies are reviewed. 相似文献
64.
Jun-Jen Liu Hsueh-Hsia Wu Tzu-Ho Chen Wan Leung Yu-Chih Liang 《International journal of molecular sciences》2015,16(8):19387-19400
15,16-Dihydrotanshinone I (DHTS) is extracted from Salvia miltiorrhiza Bunge which is a functional food in Asia. In this study, we investigated the apoptotic effect of DHTS on the human acute myeloid leukemia (AML) type III HL-60 cell line. We found that treatment with 1.5 μg/mL DHTS increased proapoptotic Bax and Bad protein expressions and activated caspases-3, -8, and -9, thus leading to poly ADP ribose polymerase (PARP) cleavage and resulting in cell apoptosis. DHTS induced sustained c-Jun N-terminal kinase (JNK) phosphorylation and Fas ligand (FasL) expression. The anti-Fas blocking antibody reversed the DHTS-induced cell death, and the JNK-specific inhibitor, SP600125, inhibited DHTS-induced caspase-3, -8, -9, and PARP cleavage. In a xenograft nude mice model, 25 mg/kg DHTS showed a great effect in attenuating HL-60 tumor growth. Taken together, these results suggest that DHTS can induce HL-60 cell apoptosis in vitro and inhibit HL-60 cell growth in vivo; the underlying mechanisms might be mediated through activation of the JNK and FasL signal pathways. 相似文献
65.
Na-Na Wang Zhi-Heng Li He Zhao Yan-Fang Tao Li-Xiao Xu Jun Lu Lan Cao Xiao-Juan Du Li-Chao Sun Wen-Li Zhao Pei-Fang Xiao Fang Fang Guang-Hao Su Yan-Hong Li Gang Li Yi-Ping Li Yun-Yun Xu Hui-Ting Zhou Yi Wu Mei-Fang Jin Lin Liu Jian Ni Jian Wang Shao-Yan Hu Xue-Ming Zhu Xing Feng Jian Pan 《International journal of molecular sciences》2015,16(1):1266-1292
Polo-like kinase 1 (PLK1) is highly expressed in many cancers and therefore a biomarker of transformation and potential target for the development of cancer-specific small molecule drugs. RO3280 was recently identified as a novel PLK1 inhibitor; however its therapeutic effects in leukemia treatment are still unknown. We found that the PLK1 protein was highly expressed in leukemia cell lines as well as 73.3% (11/15) of pediatric acute myeloid leukemia (AML) samples. PLK1 mRNA expression was significantly higher in AML samples compared with control samples (82.95 ± 110.28 vs. 6.36 ± 6.35; p < 0.001). Kaplan-Meier survival analysis revealed that shorter survival time correlated with high tumor PLK1 expression (p = 0.002). The 50% inhibitory concentration (IC50) of RO3280 for acute leukemia cells was between 74 and 797 nM. The IC50 of RO3280 in primary acute lymphocytic leukemia (ALL) and AML cells was between 35.49 and 110.76 nM and 52.80 and 147.50 nM, respectively. RO3280 induced apoptosis and cell cycle disorder in leukemia cells. RO3280 treatment regulated several apoptosis-associated genes. The regulation of DCC, CDKN1A, BTK, and SOCS2 was verified by western blot. These results provide insights into the potential use of RO3280 for AML therapy; however, the underlying mechanisms remain to be determined. 相似文献
66.
Kun-Cheng Li Yu-Ling Ho Wen-Tsong Hsieh Shyh-Shyun Huang Yuan-Shiun Chang Guan-Jhong Huang 《International journal of molecular sciences》2015,16(1):1736-1754
Apigenin-7-glycoside (AP7Glu) with multiple biological activities is a flavonoid that is currently prescribed to treat inflammatory diseases such as upper respiratory infections. Recently, several studies have shown that its anti-inflammatory activities have been strongly linked to the inhibition of secretion of pro-inflammatory proteins, such as inducible nitric oxide synthase (iNOs) and cyclooxygenase-2 (COX-2) induced through phosphorylation nuclear factor-κB (NF-κB) and mitogen-activated protein kinases (MAPK) pathways. Additionally, inflammation, which can decrease the activities of antioxidative enzymes (AOEs) is also observed in these studies. At the same time, flavonoids are reported to promote the activities of heme oxygenase-1 (HO-1) decreased by LPS. The purpose of this study was to assess these theories in a series of experiments on the suppressive effects of AP7Glu based on LPS-induced nitric oxide production in RAW264.7 macrophages in vitro and acute lung injury in mice in vivo. After six hours of lipopolysaccharide (LPS) stimulation, pulmonary pathological, myeloperoxidase (MPO) activity, total polymorphonuclear leukocytes (PMN) cells, cytokines in bronchoalveolar lavage fluid (BALF) and AOEs, are all affected and changed. Meanwhile, our data revealed that AP7Glu not only did significantly inhibit the LPS-enhanced inflammatory activity in lung, but also exhibited anti-inflammatory effect through the MAPK and inhibitor NF-κB (IκB) pathways. 相似文献
67.
目的:通过短时间吸入染毒可初步了解阿维茵素原药经呼吸道进入机体而引起动物的中毒症状及死亡率,求出吸入染毒的LC50,为急性吸入毒性分级、标签管理和其它有关的毒理学研究提供科学的参考资料,也能够为制定生产和应用过程中的防护措施提供依据。方法:GB15670-1995《农药登记毒理学试验方法》中吸入染毒方法。结果:阿维菌素原药急性吸入LC如(2h):雌性-584(430-794)mg/m……3,雄性-681(---)mg/m^3,根据我国农药的急性毒性分级标准,阿维菌素原药对雌雄大鼠急性吸入毒性均属中毒。 相似文献
68.
Shan-Shan Kong Jin-Jun Liu Xiao-Jiang Yu Yi Lu Wei-Jin Zang 《International journal of molecular sciences》2012,13(11):14311-14325
Reactive oxygen species (ROS) production is an important mechanism in myocardial ischemia and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is one of major sources of ROS in the heart. Previous studies showed that vagus nerve stimulation (VNS) is beneficial in treating ischemic heart diseases. However, the effect of VNS on ROS production remains elusive. In this study, we investigated the role of VNS onischemia-induced ROS production. Our results demonstrated that VNS alleviated the myocardial injury, attenuated the cardiac dysfunction, reserved the antioxidant enzyme activity and inhibited the formation of ROS as evidenced by the decreased NADPH oxidase (Nox) activity and superoxide fluorescence intensity as well as the expression of p67phox, Rac1 and nitrotyrosine. Furthermore, VNS resulted in the phosphorylation and activation of adenosine monophosphate activated protein kinase (AMPK), which in turn led to an inactivation of Nox by protein kinase C (PKC); however, the phenomena were repressed by the administration of a muscarinic antagonist atropine. Taken together, these data indicate that VNS decreases ROS via AMPK-PKC-Nox pathway; this may have potential importance for the treatment of ischemic heart diseases. 相似文献
69.
Yang Ji Iris Yuwen Zhou Bensheng Qiu Phillip Zhe Sun 《Israel journal of chemistry》2017,57(9):809-824
Chemical exchange saturation transfer (CEST) MRI provides a sensitive detection mechanism for imaging dilute labile protons, complementing the routine radiological exams. Enormous progress has been achieved in CEST MRI and image analysis, from the mathematical modeling, CEST agent design, and most importantly, increasing adoption of CEST imaging in the clinical setting. Therefore, CEST imaging represents an emerging field that involves multiple disciplines and together made a remarkable transition from the simplistic CEST-weighted MRI to quantitative CEST (qCEST) analysis. This review focuses on the recent advancements in CEST quantification techniques and findings of in vivo CEST imaging in representative disorders of ischemia, tumor, and epilepsy. In addition, limitations of current CEST methodologies are examined that should help guide future development of more sensitive and quantitative CEST imaging techniques and ultimately, facilitate their adoption in the clinical setting. 相似文献
70.
Stanislav R. Kurpe Sergei Yu. Grishin Alexey K. Surin Alexander V. Panfilov Mikhail V. Slizen Saikat D. Chowdhury Oxana V. Galzitskaya 《International journal of molecular sciences》2020,21(24)
At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and artificial origin to combat pathogens. AMPs have several points that determine their biological activity. We analyzed the structural properties of AMPs, as well as described their mechanism of action and impact on pathogenic bacteria and viruses. Recently published data on the development of new AMP drugs based on a combination of molecular design and genetic engineering approaches are presented. In this article, we have focused on information on the amyloidogenic properties of AMP. This review examines AMP development strategies from the perspective of the current high prevalence of antibiotic-resistant bacteria, and the potential prospects and challenges of using AMPs against infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 相似文献